This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,308.88 Firm Fixed Price Delivery Order is for the supply of GLIMEPIRIDE 4 MG TABLET 100S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of November 29, 2024.
Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
The contract award reviewed does not have a set-aside designation, indicating open competition. This delivery order is a part of Amerisourcebergen's broader contracting relationship with various federal agencies, particularly the DLA, to supply a wide range of critical medical commodities across multiple therapeutic areas.
Generated 2/26/25, 9:45 AM